REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century

D. O. Claassen, Keith Anthony Josephs, J. E. Ahlskog, M. H. Silber, M. Tippmann-Peikert, Bradley F Boeve

Research output: Contribution to journalArticle

249 Citations (Scopus)

Abstract

Background: Idiopathic REM sleep behavior disorder (RBD) may be the initial manifestation of synucleinopathies (Parkinson disease [PD], multiple system atrophy [MSA], or dementia with Lewy bodies [DLB]). Methods: We used the Mayo medical records linkage system to identify cases presenting from 2002 to 2006 meeting the criteria of idiopathic RBD at onset, plus at least 15 years between RBD and development of other neurodegenerative symptoms. All patients underwent evaluations by specialists in sleep medicine to confirm RBD, and behavioral neurology or movement disorders to confirm the subsequent neurodegenerative syndrome. Results: Clinical criteria were met by 27 patients who experienced isolated RBD for at least 15 years before evolving into PD, PD dementia (PDD), DLB, or MSA. The interval between RBD and subsequent neurologic syndrome ranged up to 50 years, with the median interval 25 years. At initial presentation, primary motor symptoms occurred in 13 patients: 9 with PD, 3 with PD and mild cognitive impairment (MCI), and 1 with PDD. Primary cognitive symptoms occurred in 13 patients: 10 with probable DLB and 3 with MCI. One patient presented with primary autonomic symptoms, diagnosed as MSA. At most recent follow-up, 63% of patients progressed to develop dementia (PDD or DLB). Concomitant autonomic dysfunction was confirmed in 74% of all patients. Conclusions: These cases illustrate that the α-synuclein pathogenic process may start decades before the first symptoms of PD, DLB, or MSA. A long-duration preclinical phase has important implications for epidemiologic studies and future interventions designed to slow or halt the neurodegenerative process.

Original languageEnglish (US)
Pages (from-to)494-499
Number of pages6
JournalNeurology
Volume75
Issue number6
DOIs
StatePublished - Aug 10 2010

Fingerprint

REM Sleep Behavior Disorder
Lewy Body Disease
Multiple System Atrophy
Parkinson Disease
Dementia
Medical Record Linkage
Synucleins
Neurobehavioral Manifestations
Movement Disorders
Neurology
Nervous System
Epidemiologic Studies
Sleep
Medicine

ASJC Scopus subject areas

  • Clinical Neurology
  • Medicine(all)

Cite this

REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. / Claassen, D. O.; Josephs, Keith Anthony; Ahlskog, J. E.; Silber, M. H.; Tippmann-Peikert, M.; Boeve, Bradley F.

In: Neurology, Vol. 75, No. 6, 10.08.2010, p. 494-499.

Research output: Contribution to journalArticle

Claassen, D. O. ; Josephs, Keith Anthony ; Ahlskog, J. E. ; Silber, M. H. ; Tippmann-Peikert, M. ; Boeve, Bradley F. / REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. In: Neurology. 2010 ; Vol. 75, No. 6. pp. 494-499.
@article{9df7ec64e86446149362be38fefd847c,
title = "REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century",
abstract = "Background: Idiopathic REM sleep behavior disorder (RBD) may be the initial manifestation of synucleinopathies (Parkinson disease [PD], multiple system atrophy [MSA], or dementia with Lewy bodies [DLB]). Methods: We used the Mayo medical records linkage system to identify cases presenting from 2002 to 2006 meeting the criteria of idiopathic RBD at onset, plus at least 15 years between RBD and development of other neurodegenerative symptoms. All patients underwent evaluations by specialists in sleep medicine to confirm RBD, and behavioral neurology or movement disorders to confirm the subsequent neurodegenerative syndrome. Results: Clinical criteria were met by 27 patients who experienced isolated RBD for at least 15 years before evolving into PD, PD dementia (PDD), DLB, or MSA. The interval between RBD and subsequent neurologic syndrome ranged up to 50 years, with the median interval 25 years. At initial presentation, primary motor symptoms occurred in 13 patients: 9 with PD, 3 with PD and mild cognitive impairment (MCI), and 1 with PDD. Primary cognitive symptoms occurred in 13 patients: 10 with probable DLB and 3 with MCI. One patient presented with primary autonomic symptoms, diagnosed as MSA. At most recent follow-up, 63{\%} of patients progressed to develop dementia (PDD or DLB). Concomitant autonomic dysfunction was confirmed in 74{\%} of all patients. Conclusions: These cases illustrate that the α-synuclein pathogenic process may start decades before the first symptoms of PD, DLB, or MSA. A long-duration preclinical phase has important implications for epidemiologic studies and future interventions designed to slow or halt the neurodegenerative process.",
author = "Claassen, {D. O.} and Josephs, {Keith Anthony} and Ahlskog, {J. E.} and Silber, {M. H.} and M. Tippmann-Peikert and Boeve, {Bradley F}",
year = "2010",
month = "8",
day = "10",
doi = "10.1212/WNL.0b013e3181ec7fac",
language = "English (US)",
volume = "75",
pages = "494--499",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century

AU - Claassen, D. O.

AU - Josephs, Keith Anthony

AU - Ahlskog, J. E.

AU - Silber, M. H.

AU - Tippmann-Peikert, M.

AU - Boeve, Bradley F

PY - 2010/8/10

Y1 - 2010/8/10

N2 - Background: Idiopathic REM sleep behavior disorder (RBD) may be the initial manifestation of synucleinopathies (Parkinson disease [PD], multiple system atrophy [MSA], or dementia with Lewy bodies [DLB]). Methods: We used the Mayo medical records linkage system to identify cases presenting from 2002 to 2006 meeting the criteria of idiopathic RBD at onset, plus at least 15 years between RBD and development of other neurodegenerative symptoms. All patients underwent evaluations by specialists in sleep medicine to confirm RBD, and behavioral neurology or movement disorders to confirm the subsequent neurodegenerative syndrome. Results: Clinical criteria were met by 27 patients who experienced isolated RBD for at least 15 years before evolving into PD, PD dementia (PDD), DLB, or MSA. The interval between RBD and subsequent neurologic syndrome ranged up to 50 years, with the median interval 25 years. At initial presentation, primary motor symptoms occurred in 13 patients: 9 with PD, 3 with PD and mild cognitive impairment (MCI), and 1 with PDD. Primary cognitive symptoms occurred in 13 patients: 10 with probable DLB and 3 with MCI. One patient presented with primary autonomic symptoms, diagnosed as MSA. At most recent follow-up, 63% of patients progressed to develop dementia (PDD or DLB). Concomitant autonomic dysfunction was confirmed in 74% of all patients. Conclusions: These cases illustrate that the α-synuclein pathogenic process may start decades before the first symptoms of PD, DLB, or MSA. A long-duration preclinical phase has important implications for epidemiologic studies and future interventions designed to slow or halt the neurodegenerative process.

AB - Background: Idiopathic REM sleep behavior disorder (RBD) may be the initial manifestation of synucleinopathies (Parkinson disease [PD], multiple system atrophy [MSA], or dementia with Lewy bodies [DLB]). Methods: We used the Mayo medical records linkage system to identify cases presenting from 2002 to 2006 meeting the criteria of idiopathic RBD at onset, plus at least 15 years between RBD and development of other neurodegenerative symptoms. All patients underwent evaluations by specialists in sleep medicine to confirm RBD, and behavioral neurology or movement disorders to confirm the subsequent neurodegenerative syndrome. Results: Clinical criteria were met by 27 patients who experienced isolated RBD for at least 15 years before evolving into PD, PD dementia (PDD), DLB, or MSA. The interval between RBD and subsequent neurologic syndrome ranged up to 50 years, with the median interval 25 years. At initial presentation, primary motor symptoms occurred in 13 patients: 9 with PD, 3 with PD and mild cognitive impairment (MCI), and 1 with PDD. Primary cognitive symptoms occurred in 13 patients: 10 with probable DLB and 3 with MCI. One patient presented with primary autonomic symptoms, diagnosed as MSA. At most recent follow-up, 63% of patients progressed to develop dementia (PDD or DLB). Concomitant autonomic dysfunction was confirmed in 74% of all patients. Conclusions: These cases illustrate that the α-synuclein pathogenic process may start decades before the first symptoms of PD, DLB, or MSA. A long-duration preclinical phase has important implications for epidemiologic studies and future interventions designed to slow or halt the neurodegenerative process.

UR - http://www.scopus.com/inward/record.url?scp=77955471094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955471094&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3181ec7fac

DO - 10.1212/WNL.0b013e3181ec7fac

M3 - Article

C2 - 20668263

AN - SCOPUS:77955471094

VL - 75

SP - 494

EP - 499

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 6

ER -